Canada · Health Canada Drug Product Database

INFANRIX-IPV

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
64893
DIN
02241284
Form
Suspension
Company as listed by source
GLAXOSMITHKLINE INC
Source status
Cancelled Post Market (2021-10-26)
Source last updated
2026-08-05

Source-listed ingredients

  • PERTUSSIS TOXOID — 25 MCG — per 0.5 ML
  • FILAMENTOUS HAEMAGGLUTININ — 25 MCG — per 0.5 ML
  • PERTACTIN — 8 MCG — per 0.5 ML
  • DIPHTHERIA TOXOID — 30 UNIT — per 0.5 ML
  • TETANUS TOXOID — 40 UNIT — per 0.5 ML
  • INACTIVATED POLIOVIRUS TYPE I — 40 UNIT — per 0.5 ML
  • INACTIVATED POLIOVIRUS TYPE II — 8 UNIT — per 0.5 ML
  • INACTIVATED POLIOVIRUS TYPE III — 32 UNIT — per 0.5 ML

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →